Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study

OBJECTIVES: Dabigatran is a direct thrombin inhibitor shown to be an effective alternative to warfarin in patients with non-valvular atrial fibrillation (AF). We evaluated the use of dabigatran in patients with bioprosthetic mitral and/or aortic valve replacement and AF. METHODS: We selected 34 and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drugs R D
Hlavní autoři: Durães, André Rodrigues, de Souza Roriz, Pollianna, de Almeida Nunes, Bianca, Albuquerque, Felipe Pinho e, de Bulhões, Fábio Vieira, de Souza Fernandes, Andre Mauricio, Aras, Roque
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2016
Témata:
Original Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4875919/
https://ncbi.nlm.nih.gov/pubmed/26892845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-016-0124-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky